Monday, April 18, 2016
Seven Bridges, a biomedical data analysis company, has signed a Collaborative Research and Development Agreement (CRADA) with the U.S. Department of Veteran Affairs (VA) to support two key research initiatives for the VA’s Million Veteran Program (MVP). The MVP is a national, voluntary research program funded by the VA’s Office of R&D, with the goal of partnering with Veterans receiving their care from the VA Healthcare System to study how genes affect health. Seven Bridges will serve as an industrial collaborator on the MVP, supporting the development of a hybrid cloud for large-scale data analysis, and a genotype-phenotype graph analysis engine.
INC Research Holdings, a global phase I to IV CRO, has announced a strategic collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP), a nonprofit organization dedicated to engaging the public and patients as partners in the clinical research process. Through this collaboration, INC and CISCRP will jointly develop and implement educational initiatives designed to bring greater awareness to the importance of clinical trial participation in advancing public health.
goBalto, a provider of cloud-based clinical study startup solutions, has released goBalto Select for optimizing site selection. With this release, goBalto becomes the first life science software vendor to offer a complete end-to-end platform for starting clinical trials, from site feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget.
SubjectWell, provider of a risk-free patient recruitment marketplace for clinical trials, has released its report on consumer perceptions of clinical trials. The SubjectWell Survey of Clinical Trial Awareness and Attitudes reveals significant education is still needed around the existence of clinical trials. Half of those surveyed (50%) had never heard of clinical trials, and only 31% felt confident or very confident that they would know how to get information about clinical trials.
DrugDev has added technology features to its platform for clinical trial optimization with its new site activation module, which can reduce startup time from months to weeks. DrugDev’s site activation technology, now available to customers directly as a SaaS solution in addition to traditional outsourcing, enables companies to enhance efficiency, improve site relationships and reduce the time spent on startup activities by at least 20%.
London-based British Standards Institution (BSI), which promotes excellence through standards development for business processes globally, and Massachusetts-based Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector collaborative building a global system for clinical research, have announced a major strategic partnership to promote excellence and improve quality and efficiency in medical product development worldwide.